stella
beta
A Phase I Study to Evaluate GFS202A in Advanced Solid Tumor Patients With Pre-cachexia or Cachexia — Stella
Recruiting
Back to Cancer Cachexia trials
Phase 1 — Early testing in a small group of people (usually 20–80) to evaluate safety, determine safe dosage, and identify side effects.
Trial locations
(1 site)
China
Sun-Yat Sen university cancer center, Guangzhou, Guangdong
View full record on ClinicalTrials.gov